Ticker: KALV

Company: Carbylan Therapeutics, Inc.

Person: Paul K Audhya, officer

Transaction date: Feb. 21, 2026

Reporting date: Feb. 24, 2026

Average share price: -14.135794979647219

Sold 5896.0 shares for 83344.65